Medusa Therapeutics Limited
PrivateCompany Overview
Medusa Therapeutics Limited is a biotechnology company that develops drug discovery technology and small molecule drugs targeting liquid-liquid phase separated biomolecular condensates.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
drug discoverybiomolecular condensatessmall molecule drugsliquid-liquid phase separationLLPSbiotech startuptherapeutic assetsdrug pipelineoncologyinfectious diseasesundruggable targetspreclinical researchout-licensingbiotech licensingcondensate biology
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medusa Therapeutics Limited Comparables
Compare Medusa Therapeutics Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nereid Therapeutics | 89% | |
| Dewpoint Therapeutics | 85% | |
| ETERN Therapeutics | 84% | |
Medusa Therapeutics Limited Funding Rounds
Historical fundraising activity
Medusa Therapeutics Limited Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Medusa Therapeutics Limited's valuation, stock price, and market status.
See something wrong or outdated?